초록 ▼

Tissue shaping methods and devices are provided. The devices can be adjusted within the body of a patient in a less invasive or non-invasive manner, such as by applying energy percutaneously or external to the patient's body. In one example, the device is positioned within the coronary sinus of the

Tissue shaping methods and devices are provided. The devices can be adjusted within the body of a patient in a less invasive or non-invasive manner, such as by applying energy percutaneously or external to the patient's body. In one example, the device is positioned within the coronary sinus of the patient so as to effect changes in at least one dimension of the mitral valve annulus. The device may also advantageously include a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field. In one example, the shape memory material is responsive to energy, such as electromagnetic or acoustic energy, applied from an energy source located outside the coronary sinus. A material having enhanced absorption characteristics with respect to the desired heating energy may also be used to facilitate heating and adjustment of the tissue shaping device.

대표청구항 ▼

What is claimed is: 1. A method of treating mitral valve disease, comprising: providing an implant comprising a body having a proximal end, a distal end, and a length extending therebetween, wherein the body comprises at least one shape memory portion consisting essentially of at least one shape me

What is claimed is: 1. A method of treating mitral valve disease, comprising: providing an implant comprising a body having a proximal end, a distal end, and a length extending therebetween, wherein the body comprises at least one shape memory portion consisting essentially of at least one shape memory material, the at least one shape memory portion extending at least half the length of the body; positioning the implant in a coronary sinus of the heart; and activating the implant with an energy source to cause the at least one shape memory portion to transform from a first configuration to a second configuration while the implant is in the coronary sinus; wherein said activating comprises activating with an energy source located outside the coronary sinus and unattached to the implant; and wherein said activating comprises activating the at least one shape memory portion with electromagnetic energy emitted from the energy source. 2. The method of claim 1, wherein said activating comprises activating the at least one shape memory portion with radio frequency (RF) energy emitted from the energy source. 3. The method of claim 1, wherein said activating comprises activating the at least one shape memory portion with a magnetic field emitted from the energy source. 4. The method of claim 1, wherein the implant is configured to exert a force on the mitral valve when the shape memory portion is in the second configuration. 5. The method of claim 1, wherein the implant is configured to be deliverable by an elongate delivery device to the coronary sinus through vasculature of the patient when the at least one shape memory portion is in the first configuration. 6. The method of claim 1, wherein the at least one shape memory material comprises a shape memory alloy. 7. The method of claim 1, wherein the at least one shape memory material comprises a shape memory polymer. 8. The method of claim 1, wherein the implant further comprises at least one fixation member configured to substantially anchor the implant within the coronary sinus. 9. The method of claim 1, wherein the body comprises a substantially arcuate shape when the at least one shape memory portion is in the second configuration. 10. The method of claim 1, wherein said activating comprises activating the last least one shape memory portion with focused ultrasound energy emitted from the energy source. 11. The method of claim 1, wherein said activating comprises increasing a temperature of the least one shape memory portion. 12. The method of claim 1, wherein said activating results in little or substantially no tissue damage to tissue proximate the implant. 13. A method of treating mitral valve disease, comprising: providing an implant comprising a body having a proximal end, a distal end, and a length extending therebetween, wherein the body comprises at least one shape memory portion consisting essentially of at least one shape memory material, the at least one shape memory portion extending at least half the length of the body; positioning the implant in a coronary sinus of the heart; and activating the implant with an energy source to cause the at least one shape memory portion to transform from a first configuration to a second configuration while the implant is in the coronary sinus; wherein said activating comprises activating the at least one shape memory portion with acoustic energy emitted from the energy source. 14. The implant of claim 13, wherein said activating comprises activating the at least one shape memory portion with focused ultrasound energy emitted from the energy source. 15. The method of claim 13, wherein the implant is configured to exert a force on the mitral valve when the shape memory portion is in the second configuration. 16. The method of claim 13, wherein the implant is configured to be deliverable by an elongate delivery device to the coronary sinus through vasculature of the patient when the at least one shape memory portion is in the first configuration. 17. The method of claim 13, wherein the at least one shape memory material comprises a shape memory alloy. 18. The method of claim 13, wherein the at least one shape memory material comprises a shape memory polymer. 19. The method of claim 13, wherein the implant further comprises at least one fixation member configured to substantially anchor the implant within the coronary sinus. 20. The method of claim 13, wherein the body comprises a substantially arcuate shape when the at least one shape memory portion is in the second configuration. 21. The method of claim 13, wherein said activating comprises increasing a temperature of the least one shape memory portion. 22. The method of claim 13, wherein said activating results in little or substantially no tissue damage to tissue proximate the implant.